Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PTGX

Protagonist Therapeutics Inc

May 06 • 04:00PM ET

103.97

+4.76 4.80 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN REGN CRSP VRTX NTLA BLUE ARWR EDIT AKRO SGMO

| Held by: IJR VTI VB IWM XBI VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.80	Insider Own	5.79%	Shs Outstand	64.23M	Perf Week	5.53%
Market Cap	6.69B	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-8.22%	Shs Float	60.12M	Perf Month	0.21%
Enterprise Value	6.15B	PEG	-	EPS next Q	2.06	Inst Own	118.51%	Short Float	13.97%	Perf Quarter	24.81%
Income	-114.71M	P/S	90.28	EPS this Y	293.70%	Inst Trans	2.51%	Short Ratio	11.42	Perf Half Y	36.89%
Sales	74.06M	P/B	10.19	EPS next Y	-119.13%	ROA	-15.94%	Short Interest	8.40M	Perf YTD	19.04%
Book/sh	10.21	P/C	12.21	EPS next 5Y	-	ROE	-17.06%	52W High	107.84 -3.59%	Perf Year	147.49%
Cash/sh	8.52	P/FCF	-	EPS past 3/5Y	7.63% -1.26%	ROIC	-17.30%	52W Low	41.28 151.83%	Perf 3Y	319.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.07% 9.96%	Gross Margin	98.04%	Volatility	3.68% 4.12%	Perf 5Y	271.06%
Dividend TTM	-	EV/Sales	83.02	EPS Y/Y TTM	-145.57%	Oper. Margin	-192.36%	ATR (14)	4.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.76	Sales Y/Y TTM	-64.36%	Profit Margin	-154.88%	RSI (14)	56.49	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	17.76	EPS Q/Q	129.01%	SMA20	2.02%	Beta	1.89	Target Price	116.31
Payout	-	Debt/Eq	0.01	Sales Q/Q	99.03%	SMA50	4.70%	Rel Volume	1.35	Prev Close	99.21
Employees	132	LT Debt/Eq	0.01	Earnings	May 05 AMC	SMA200	29.26%	Avg Volume	735.47K	Price	103.97
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	109.99% 381.68%	Trades		Volume	989,856	Change	4.80%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)